Andrew Almond
Director/Miembro de la Junta en Imperagen Ltd. .
Cargos activos de Andrew Almond
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Imperagen Ltd.
 Imperagen Ltd. Miscellaneous Commercial ServicesCommercial Services Imperagen Ltd. is a British biotechnology company founded in 2021 that engages in research and experimental development. The company is based in Manchester, UK. | Director/Miembro de la Junta | 23/11/2021 | - |
Historial de carrera de Andrew Almond
Antiguos cargos conocidos de Andrew Almond.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| C4X DISCOVERY HOLDINGS PLC | Director Técnico/Científico/I+D | 01/01/2008 | - |
| Fundador | 01/01/2008 | - | |
C4X Discovery Ltd.
 C4X Discovery Ltd. Pharmaceuticals: MajorHealth Technology C4X Discovery Ltd. engages in the discovery and development of medical drugs. It uses its NMR-based technology to solve the dynamic 3D structures of a broad range of biomolecules, including peptides, cofactors, oligonucleotides and carbohydrates. The company was founded by Andrew Almond and Charles Douglas Blundell in January 2008 and is headquartered in Manchester, the United Kingdom. | Director/Miembro de la Junta | 01/01/2008 | - |
| Director Técnico/Científico/I+D | 14/10/2011 | - | |
| Fundador | 23/11/2009 | - | |
| Presidente | 23/11/2009 | 14/10/2011 |
Formación de Andrew Almond.
| The University of Edinburgh | Undergraduate Degree |
| The University of Manchester | Doctorate Degree |
Estadísticas
Internacional
| Reino Unido | 5 |
| Israel | 2 |
Operativa
| Director/Board Member | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| C4X DISCOVERY HOLDINGS PLC | Health Technology |
| Empresas privadas | 2 |
|---|---|
C4X Discovery Ltd.
C4X Discovery Ltd. Pharmaceuticals: MajorHealth Technology C4X Discovery Ltd. engages in the discovery and development of medical drugs. It uses its NMR-based technology to solve the dynamic 3D structures of a broad range of biomolecules, including peptides, cofactors, oligonucleotides and carbohydrates. The company was founded by Andrew Almond and Charles Douglas Blundell in January 2008 and is headquartered in Manchester, the United Kingdom. | Health Technology |
Imperagen Ltd.
Imperagen Ltd. Miscellaneous Commercial ServicesCommercial Services Imperagen Ltd. is a British biotechnology company founded in 2021 that engages in research and experimental development. The company is based in Manchester, UK. | Commercial Services |
- Bolsa de valores
- Insiders
- Andrew Almond
- Experiencia
